Treatment of Huntington's Disease by Inhibition of Caspase-6 Cleavage Using CRISPR Base Editing

被引：0
|
作者：
Shirguppe, Shraddha [1 ]
机构：
[1] UIUC, Dept Bioengn, Urbana, IL USA
来源：
MOLECULAR THERAPY | 2023年 / 31卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
1562
引用
收藏
页码：734 / 734
页数：1
相关论文
共 50 条
  • [41] Loss of function of DJ-1 triggered by Parkinson's disease-associated mutation is due to proteolytic resistance to caspase-6
    E Giaime
    C Sunyach
    C Druon
    S Scarzello
    G Robert
    S Grosso
    P Auberger
    M S Goldberg
    J Shen
    P Heutink
    J Pouysségur
    G Pagès
    F Checler
    C Alves da Costa
    Cell Death & Differentiation, 2010, 17 : 158 - 169
  • [42] Generation of New Isogenic Models of Huntington's Disease Using CRISPR-Cas9 Technology
    Dabrowska, Magdalena
    Ciolak, Agata
    Kozlowska, Emilia
    Fiszer, Agnieszka
    Olejniczak, Marta
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (05)
  • [43] Harnessing non- Watson-Crick's base pairing to enhance CRISPR effectors cleavage activities and enable gene editing in mammalian cells
    Gao, Shuliang
    Guan, Huiwen
    Bloomer, Hanan
    Wich, Douglas
    Song, Donghui
    Khirallah, Jennifer
    Ye, Zhongfeng
    Zhao, Yu
    Chen, Mengting
    Xu, Chutian
    Liu, Lihan
    Xu, Qiaobing
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2024, 121 (02)
  • [44] In vivo CRISPR-Cas9 genome editing in mice identifies genetic modifiers of somatic CAG repeat instability in Huntington's disease
    Mouro Pinto, Ricardo
    Murtha, Ryan
    Azevedo, Antonio
    Douglas, Cameron
    Kovalenko, Marina
    Ulloa, Jessica
    Crescenti, Steven
    Burch, Zoe
    Oliver, Esaria
    Kesavan, Maheswaran
    Shibata, Shota
    Vitalo, Antonia
    Mota-Silva, Eduarda
    Riggs, Marion J.
    Correia, Kevin
    Elezi, Emanuela
    Demelo, Brigitte
    Carroll, Jeffrey B.
    Gillis, Tammy
    Gusella, James F.
    Macdonald, Marcy E.
    Wheeler, Vanessa C.
    NATURE GENETICS, 2025, 57 (02) : 314 - 322
  • [45] A rational mechanism for combination treatment of Huntington's disease using lithium and rapamycin
    Sarkar, Sovan
    Krishna, Gauri
    Imarisio, Sara
    Saiki, Shinji
    O'Kane, Cahir J.
    Rubinsztein, David C.
    HUMAN MOLECULAR GENETICS, 2008, 17 (02) : 170 - 178
  • [46] Identification of combinatorial drug regimens for treatment of Huntington's disease using Drosophila
    Agrawal, N
    Pallos, J
    Slepko, N
    Apostol, BL
    Bodai, L
    Chang, LW
    Chiang, AS
    Thompson, LM
    Marsh, JL
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (10) : 3777 - 3781
  • [47] Histone deacetylase 6 inhibition compensates for the transport deficit in Huntington's disease by increasing tubulin acetylation
    Dompierre, Jim P.
    Godin, Juliette D.
    Charrin, Benedicte C.
    Cordelieres, Fabrice P.
    King, Stephen J.
    Humbert, Sandrine
    Saudou, Frederic
    JOURNAL OF NEUROSCIENCE, 2007, 27 (13): : 3571 - 3583
  • [48] Track: Protein and Ligand - A New Marriage Between an Old Couple Structural Characterization of Selective and Potent Allosteric Inhibitors of Caspase-6 for Neurodegenerative Disease Treatment
    Sagarbarria, Irina
    Hardy, Jeanne
    PROTEIN SCIENCE, 2023, 32
  • [49] ALLELE SPECIFIC GENE EDITING FOR HUNTINGTON'S DISEASE MEDIATED BY THE KAMICAS9 SELF-INACTIVATING CRISPR/CAS9 SYSTEM
    Deglon, Nicole
    Vachey, Gabriel
    Rey, Maria
    Perrier, Anselme
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2018, 89 : A90 - A90
  • [50] Total Lowering of HTT Using Vectorized Antisense Oligonucleotides for the Treatment of Huntington's Disease
    Adams, Johanna
    Goulet, Martin
    Ramachandran, Shyam
    Elmer, Bradford
    Mueller, Christian
    MOLECULAR THERAPY, 2023, 31 (04) : 583 - 584
12345